The resource center notes that as many as 3,000 patients have filed an Actos lawsuit against drug maker Takeda Pharmaceuticals alleging they developed bladder cancer.
New York, NY (PRWEB) April 11, 2013
The diabetes drug safety advocates at DrugRisk.com are announcing new information on the site for patients who have taken the diabetes medication Actos. In the first trial against manufacturer Takeda Pharmaceuticals over allegations the drug caused bladder cancer, a doctor has testified Actos was the main cause.
The goal of DrugRisk is to improve the safety of patients taking popular prescription drugs by providing the most up-to-date warnings, recalls, studies and legal news. Visitors can determine if others have experienced similar side effects and decide if they need legal advice.
DrugRisk contains warnings from experts such as the FDA and European Medicines Agency*, who have warned that long-term use of Actos may be associated with an increased bladder cancer risk. The drug has also been banned in France and Germany**.
Although Actos remains on the market in the United States, the resource center notes that as many as 3,000 patients have filed an Actos lawsuit against drug maker Takeda Pharmaceuticals alleging they developed bladder cancer***.
Now, DrugRisk has added updated legal news from the first Actos lawsuit to begin trial last month in California. In the case of Jack Cooper, a retired man alleging his terminal bladder cancer was caused by Actos, Dr. Norm D. Smith, an assistant professor of urology and surgery at the University of Chicago, testified Actos was the “most substantial causative factor” of his cancer****.
Anyone affected by bladder cancer after taking Actos is urged to contact DrugRisk or speak with a lawyer about their legal rights as soon as possible. Lawyers are still helping those affected file claims.
Due to the specialized nature of drug injury litigation, however, DrugRisk only recommends lawyers and law firms who have already handled Actos lawsuits.
To learn more about the studies linking Actos to bladder cancer, as well as side effects and legal news, or to speak with a lawyer, visit http://www.DrugRisk.com today.
*fda.gov/ForConsumers/ConsumerUpdates/ucm263431.htm#Actos; ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/public_health_alerts/2011/07/hu an_pha_detail_000033.jsp&mid=WC0b01ac058001d126
***bloomberg.com/news/2013-03-05/takeda-put-actos-sales-ahead-of-user-safety-witness-says.html; Cooper v. Takeda Pharmaceuticals America Inc., CGC-12-518535, California Superior Court (Los Angeles).
****Claran McEvoy, March 26, 2013, Law360, “Actos 'Most Substantial' Factor In Man's Cancer, Doc Testifies”